Teachers Retirement System of The State of Kentucky Has $1.54 Million Position in Teleflex Incorporated $TFX

Teachers Retirement System of The State of Kentucky trimmed its position in shares of Teleflex Incorporated (NYSE:TFX) by 29.4% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 12,617 shares of the medical technology company’s stock after selling 5,262 shares during the quarter. Teachers Retirement System of The State of Kentucky’s holdings in Teleflex were worth $1,543,000 as of its most recent SEC filing.

Other large investors have also added to or reduced their stakes in the company. Norges Bank bought a new stake in Teleflex during the 2nd quarter worth approximately $65,826,000. Thrivent Financial for Lutherans grew its stake in shares of Teleflex by 1,161.0% in the third quarter. Thrivent Financial for Lutherans now owns 550,449 shares of the medical technology company’s stock worth $67,353,000 after purchasing an additional 506,796 shares during the last quarter. Qube Research & Technologies Ltd increased its holdings in Teleflex by 100.1% in the second quarter. Qube Research & Technologies Ltd now owns 606,804 shares of the medical technology company’s stock valued at $71,821,000 after purchasing an additional 303,521 shares during the period. Wedge Capital Management L L P NC bought a new position in Teleflex during the 3rd quarter worth $26,929,000. Finally, Boston Partners lifted its holdings in Teleflex by 112.5% during the 2nd quarter. Boston Partners now owns 380,933 shares of the medical technology company’s stock worth $45,085,000 after buying an additional 201,652 shares during the period. Institutional investors own 95.62% of the company’s stock.

Teleflex Price Performance

Shares of NYSE:TFX opened at $117.47 on Friday. Teleflex Incorporated has a twelve month low of $100.18 and a twelve month high of $143.32. The firm has a market capitalization of $5.19 billion, a price-to-earnings ratio of -5.72, a PEG ratio of 0.77 and a beta of 0.87. The stock’s 50 day moving average is $111.15 and its 200-day moving average is $118.70. The company has a quick ratio of 2.01, a current ratio of 2.54 and a debt-to-equity ratio of 0.81.

Teleflex (NYSE:TFX) last posted its earnings results on Thursday, February 26th. The medical technology company reported $1.93 EPS for the quarter, missing the consensus estimate of $3.73 by ($1.80). Teleflex had a positive return on equity of 14.30% and a negative net margin of 30.56%.The business had revenue of $569.00 million for the quarter, compared to the consensus estimate of $912.57 million. During the same period in the previous year, the firm earned $3.89 earnings per share. The company’s revenue was down 28.5% on a year-over-year basis. Teleflex has set its FY 2026 guidance at 6.250-6.550 EPS. Sell-side analysts forecast that Teleflex Incorporated will post 13.98 EPS for the current fiscal year.

Teleflex Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, March 31st. Investors of record on Friday, March 6th will be issued a dividend of $0.34 per share. The ex-dividend date is Friday, March 6th. This represents a $1.36 annualized dividend and a yield of 1.2%. Teleflex’s dividend payout ratio is -6.62%.

Wall Street Analyst Weigh In

Several brokerages have recently weighed in on TFX. Needham & Company LLC increased their price target on Teleflex from $138.00 to $147.00 and gave the company a “buy” rating in a research note on Thursday, February 26th. Truist Financial increased their target price on shares of Teleflex from $120.00 to $135.00 and gave the company a “hold” rating in a research report on Thursday, December 18th. Royal Bank Of Canada boosted their price target on shares of Teleflex from $115.00 to $125.00 and gave the stock a “sector perform” rating in a research report on Friday, February 27th. Weiss Ratings reissued a “sell (d)” rating on shares of Teleflex in a research note on Monday, December 29th. Finally, Wall Street Zen lowered shares of Teleflex from a “buy” rating to a “hold” rating in a report on Saturday, November 15th. Two equities research analysts have rated the stock with a Buy rating, four have given a Hold rating and two have issued a Sell rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Hold” and a consensus price target of $140.83.

Teleflex Profile

Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.

The company’s offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.